Using its first installed robot, VolitionRx has recently completed the analysis of a first NuQ® assay on the complete set of 4,800 blood samples for its large retrospective, symptomatic population colorectal cancer study in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark.

Read More:
VolitionRx adds three new laboratory automation systems to expedite sample analysis for its large ongoing clinical trials

Scroll to Top